WatchPAT 400

The next generation of sleep apnea diagnostics
WatchPAT 400 delivers a streamlined, app-connected experience designed to support workflow efficiency, patient compliance, and seamless cloud connectivity, while building on the proven WatchPAT foundation.

WatchPAT ®400

The next generation of sleep apnea diagnostics
WatchPAT 400 delivers a streamlined, app-connected experience designed to support workflow efficiency, patient compliance, and seamless cloud connectivity, while building on the proven WatchPAT foundation.

Interested in Learning More About WatchPAT 400?

Fill out the form below and an Itamar rep will be in touch.

Join ZOLL Itamar at SLEEP 2026 Booth

to explore how our commitment to innovation continues to shape the future of sleep diagnostics.

A Simpler, More Connected
Testing Experience

WatchPAT 400 is designed to support a more efficient testing experience for both patients and providers. With app connectivity, immediate access to study results, and the proven WatchPAT approach, it brings a more connected workflow to home sleep testing.

  • Immediate access to study results
  • Enhanced patient communication
  • App-connected workflow
  • Proven WatchPAT accuracy

Built on the Tradition
Trusted WatchPAT Technology

WatchPAT 400 is the latest evolution in the WatchPAT family of home sleep apnea testing solutions, extending the simple, accurate, and reliable approach providers have come to expect.

Operational Efficiency
  • Streamlined clinical decision-making
  • Intuitive setup process
Advanced WatchPAT Foundation Includes trusted advanced WatchPAT features
  • 7 channels with 4 respiratory indices
  • Central sleep apnea identification
  • Afib identification
  • Arrhythmia Detection – AFib events and premature beats*
  • Hypoxic burden
* The WatchPAT® is not intended to be used as a diagnostic device for any cardiac arrhythmia and is not intended to
replace traditional methods of diagnosis for cardiac arrhythmias. In cases where the longest AFib episode detected is
shorter than 60 seconds, review of the peripheral arterial tonometry signal for an irregularly irregular rhythm in the location of the episode is
recommended. The WatchPAT® may not detect short AFib episodes (<60 seconds).
 
Twitter
Skip to content